Işletim Giderleri Değişiklik Tarih
AbbVie USD 10.52B 258M 2026-09
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Amarin USD 51.48M 113K 2025-12
AstraZeneca USD 11.55B 674M 2026-09
BioCryst Pharmaceuticals USD -397.38M 517.17M 2026-09
DBV Technologies USD 64.8M 16.9M 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Halozyme Therapeutics USD 198M 4.66M 2026-09
Heron Therapeutics USD 40.55M 1.46M 2025-12
Ionis Pharmaceuticals USD 373M 2.76M 2026-09
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Neurocrine Biosciences USD 779.7M 40.6M 2026-09
Novartis USD 9.88B 325M 2026-09